- Welcome Physicians
- About RADIESSE Dermal Filler
- Uses & Limitations
- Clinical Education
- Clinical Studies
- Marketing Support
- Patient Access Program
- Insurance Reimbursement
To view more before and after cases, click here.
Insurance Reimbursement Information – Radiesse® Dermal Filler
BioForm Medical strongly recommends that pre-approval (or prior authorization) for coverage of RADIESSE dermal filler for HIV-associated facial lipoatrophy is obtained. To that end, we have provided the following information to aid you regarding diagnosis, procedure, and product codes.
It is recommended that the individual insurance carrier/provider is contacted regarding its specific reimbursement levels or to confirm reimbursement levels. BioForm Medical, Inc. does not represent nor warrant that insurance reimbursement will be available.
Initial Visit
| Diagnosis: | 272.6 | Lipodystrophy |
| 42 | HIV | |
| Procedure: | Appropriate CPT E&M Codes for visit type and service level | |
| 11951 | Subcutaneous injection or filling material 1.1 to 5.0cc |
|
| 11952 | Subcutaneous injection of filling material 5.1 to 10.0cc |
|
| 11954 | Subcutaneous injection of filling material over 10.00cc |
|
| 17999 | Unlisted procedure, skin, mucous membrane and subcutaneous tissue |
|
| Product: | 8699 | Prosthetic NOS Description quantity (cc) and description of intradermal filling material |